2010 - Concurrent PPIs and antibiotics for incident C. difficile infection were associated with increased risk for recurrent infection

Fekete, Thomas
October 2010
ACP Journal Club;10/19/2010, Vol. 153 Issue 4, p11
Academic Journal
The article presents the outcomes of a scientific study which aims to find out the risk associated with concurrent prescription of proton pump inhibitors (PPIs) and antibiotics for incident Clostridium difficile infection (CDI). Undertaken by A. Linsky and colleagues it made the use of PPIs based on their clinical effectiveness and perceived safety. It was seen that concurrent prescription for PPI and antibiotics for incident CDI was associated with an increased risk for recurrent CDI.


Related Articles

  • Proton Pump Inhibitors and Clostridium Difficile Infection: Are We Propagating an Already Rapidly Growing Healthcare Problem? Patil, Rashmee; Blankenship, LeAnn // Gastroenterology Research;Oct2013, Vol. 6 Issue 5, p171 

    Proton pump inhibitors (PPIs) have been associated with Clostridium difficile infection (CDI) in several recent studies. The exact mechanism through which PPIs may cause Clostridium difficile infection is not well understood. One potential mechanism to explain this association may be that...

  • Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. Dial, Sandra; Kezouh, Abbas; Dascal, Andre; Barkun, Alan; Suissa, Samy // CMAJ: Canadian Medical Association Journal;10/7/2008, Vol. 179 Issue 8, p767 

    Background: Previous observations have indicated that infection with Clostridium difficile occurs almost exclusively after exposure to antibiotics, but more recent observations have suggested that prior antibiotic exposure may be less frequent among cases of community acquired disease. Methods:...

  • Proton Pump Inhibitors and Hospitalization for Clostridium Difficile--Associated Disease: A Population-Based Study. Lowe, Donna O.; Mamdani, Muhammad M.; Kopp, Alexander; Low, Donald E.; Juurlink, David N. // Clinical Infectious Diseases;11/15/2006, Vol. 43 Issue 10, p1272 

    Background. Previous studies have examined the association between proton pump inhibitor (PPI) use and the risk of Clostridium difficile-associated disease (CDAD), with conflicting results. Whether outpatient PPI use influences the risk of hospital admission for CDAD among older patients who...

  • SHORING UP DEFENCES AGAINST C DIFFICILE. Saker, Lance // Pulse;3/9/2006, Vol. 66 Issue 10, p41 

    The article examines the extent of the surge in Clostridium difficile cases in Great Britain. C. difficile is responsible for a range of clinical conditions ranging from asymptomatic carriage to diarrhea, colitis, toxic megacolon and sometimes death. Several causes of the C. difficile incidence...

  • Controlling Clostridium difficile. Hajkowicz, Krispin; McFarlane, Mark // Australian Prescriber;Aug2013, Vol. 36 Issue 4, p121 

    Clostridium difficile infection causes colitis and is closely associated with the use of antimicrobials, probably due to disruption of the normal bowel flora. Avoiding inappropriate antimicrobial use is the most important way to prevent this potentially life-threatening infection. Emergent...

  • Aggression of C-difficile Infections in PPI Consumers. Daniell, Harry W // American Journal of Gastroenterology;Jun2014, Vol. 109 Issue 6, p922 

    A letter to the editor in response to a research article related to the association between proton pump inhibitor (PPI) use and clostridium difficile (C-difficile) infection (CDI) recurrences published in a previous issue is presented.

  • Response to Daniell. Freedberg, Daniel E; Salmasian, Hojjat; Friedman, Carol; Abrams, Julian A // American Journal of Gastroenterology;Jun2014, Vol. 109 Issue 6, p922 

    A letter to the editor is presented in response to an article related to association between proton pump inhibitor (PPI) use and C-difficile infection (CDI) recurrences, published in a previous issue.

  • Fluoroquinolone use a risk factor for CDAD.  // Reactions Weekly;1/14/2006, Issue 1084, p4 

    The article reports on the results of a cohort study regarding the association of the use of fluoroquinolones with a higher risk of Clostridium difficile-associated diarrhoea. Comparison of the use of fluoroquinolones with the use of other antibacterials, proton pump inhibitors, antacids and...

  • Preliminary investigation of environmental prevalence of Clostridium difficile affecting inpatients in a north Indian hospital. Vaishnavi, C.; Singh, M. // Indian Journal of Medical Microbiology;Jan2012, Vol. 30 Issue 1, p89 

    A preliminary study was conducted to see the prevalence of Clostridium difficile in patients and their environment in a tertiary care hospital. Seventy-nine fecal specimens from hospitalized patients, 176 swab samples from beds and 48 from hands of hospital personnel were investigated....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics